VC firms
Ahren Innovation Capital
Edit

Ahren Innovation Capital

Trusted
https://www.ahreninnovationcapital.com/
Last activity: 28.10.2026
Active
Invests in categories: AIArtificial IntelligenceComputingDeepTechHardwareHealthTechPlatformQuantumRoboticsSoftware
Ahren is a deep tech and deep science investment firm set up by Alice Newcombe-Ellis alongside co-Founding Science Partners. Together, these Founders created companies and/or technologies that are today valued in excess of $100BN combined. The firm was established from first principles with a mission to be disruptive as an investment institution, with a new model – genuine partnership between the creators of deep technology and deep science, and commercially active, long-term capital, to harness tremendous global talent and build and exponentially accelerate the next generation of great enterprises. Ahren’s Portfolio companies include AI21 Labs, Graphcore, Zapata Computing, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics among others. Ahren has >$800M AUM and has team members in Cambridge (UK), London, and Boston.
TwitterLinkedInEmail
Followers
1.38K
News
32
Portfolio
28
Persons
25
Mentions
30

Overview

Location
United Kingdom, England, London
Employees
11-50
Founded date
2017
Investment Type
Venture Capital
Investment Stage
Seed; Series A; Series B

Portfolio 28

DateNameWebsiteTotal RaisedLocation
Sign up to seeSign up to seeSign up to seeSign up to seeSign up to see
Dec 10, 2025Nu Quantumnu-quantum.com$134.85MUnited Kingdom
Apr 2, 2024Sunfiresunfire.de$914.06MGermany
Sep 12, 2023Zapata AIzapata.aiUnited States, Massachusetts, Boston
May 31, 2023biomodalbiomodal.comUnited Kingdom, England, Cambridge
Jan 22, 2023Pictura Biopictura.bio
Oct 20, 2022AmbiRoboticsambirobotics.com$101.1MUnited States, California, Emeryville
Aug 15, 2022Constructive Bioconstructive.bio$73MUnited Kingdom, England, Little Chesterford
Jul 12, 2022AI21 Labsai21.com$781.5MIsrael
Mar 18, 2022Heirloomheirloomcarbon.com$203MUnited States, California, San Francisco
Show more

Persons 25

DateFirst NameLast NameTitleLinkedInLocation
Sign up to seeSign up to seeSign up to seeSign up to seeSign up to seeSign up to see
JoannaGreenInvestment Professional
PeterLourensz, FCA
ProfessorRoberto Cipolla
JanuszMarecki, PhD
SirShankar BalasubramanianFounding Partner
SirVenki Ramakrishnan
SabilaChilaeva, PhD
AnujNanwani
PeterBaines
Show more

News 32

DateTitleDescription
Sign up to seeSign up to seeSign up to see
May 4, 2021ZOE Announces $53M Total Raise From Investors Including Fund Backed By Top Scientists, and Two-Time Super Bowl Champion Eli Manning
Apr 22, 2021Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
Feb 25, 2021Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Feb 3, 2021Applications Open: AI/ML Deal Flow Internship
Feb 3, 2021Applications Open: Global Venture Intern
Jan 14, 2021Applications Open for Summer 2021: Life Sciences Summer Associate
Jan 14, 2021Applications Open for Summer 2021: Technology Summer Associate
Dec 18, 2020GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestones
Nov 19, 2020Zapata Computing Announces $38 Million Funding for Series B Financing to Accelerate the Commercial Adoption of Quantum Computing Technologies and Applications
Show more

Mentions in press and media 30

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Oct 26, 2026Coherence Neuro Brings in $45M Series A Funding SAN FRANCISCO, CA, Coherence Neuro, a neurotechnology company developing implantable devices to monitor and potentially treat cancer, raised $45 million in Series A funding co-led by Founders Fund and the OpenAI Startup Fund. >> Clic...
Jan 14, 2026OutSee Secures £2.5M, Propels AI Genomics for Drug DiscoveryOutSee secured a significant £2.5M seed funding round. Ahren Innovation Capital spearheaded the investment. This capital fuels OutSee's groundbreaking AI-powered Nomaly platform. Nomaly uses a "genomics-first" approach. It pr...
Jan 12, 2026OutSee: £2.5 Million Seed Round Completed And Partnership With o2h DiscoveryOutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target c...
Dec 10, 2025Nu Quantum Raises $60M Series A in Largest Financing Round for Quantum Computer NetworkingNew investors, including National Grid Partners, Gresham House Ventures and Morpheus Ventures, validate growing demand for modular, scaling networking technologies within quantum computing. The oversubscribed funding round will accelerate N...
Sep 17, 2025Hiverge Raises $5M in Seed FundingHiverge, a Cambridge, UK-based company enabling businesses access to algorithms that continually adapt to changing environments, raised $5M in Seed funding. The round was led by Flying Fish Ventures with Ahren Innovation Capital and Jeff De...
Jul 24, 2025Bitfount Secures $8M to Revolutionize Clinical Research with Federated AIBitfount secured $8 million in Series A funding. This capital fuels its privacy-preserving federated AI platform. It revolutionizes clinical research collaboration. The technology eliminates raw data sharing. It brings algorithms directly t...
Jul 24, 2025Bitfount raises $8m in Series A funding roundLONDON, UK, July 23, 2025 – Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Ad...
Jul 23, 2025Bitfount raises $8M to unlock clinical research data with federated AILondon-based Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Bitfount removes the data-...
Jul 23, 2025London’s Bitfount raises €6.8 million to break down clinical research data silos with federated AI networkHealthTech platform Bitfount, a British federated AI platform innovating clinical research collaboration, has secured €6.8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Advi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Ahren Innovation Capital

When was Ahren Innovation Capital founded?

Ahren Innovation Capital was founded in 2017.

How many startups has Ahren Innovation Capital invested in?

Ahren Innovation Capital has 28 portfolio companies on Parsers VC, among them Nu Quantum, Sunfire and Zapata AI.

What is the latest news about Ahren Innovation Capital?

Parsers VC has 32 news items about Ahren Innovation Capital, among them “ZOE Announces $53M Total Raise From Investors Including Fund Backed By Top Scientists, and Two-Time Super Bowl Champion Eli Manning” (May 4, 2021) and “Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging” (Apr 22, 2021).

What has the press written about Ahren Innovation Capital?

Parsers VC has collected 30 articles mentioning Ahren Innovation Capital, among them “Coherence Neuro Brings in $45M Series A Funding” (Oct 26, 2026) and “OutSee Secures £2.5M, Propels AI Genomics for Drug Discovery” (Jan 14, 2026).

Is Ahren Innovation Capital still active?

Yes, Ahren Innovation Capital is active; its latest activity on Parsers VC dates from Oct 28, 2026.